OMC
IMA

OUP Management Company’s ImageneBio Inc IMA Stock Holding History

OUP Management Company’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$116K Buy
+2,236
New +$135K 0.26% 11

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OUP Management Company's IMA Position: Q3 2023 in Review

OUP Management Company opened a new position in ImageneBio Inc (IMA) in Q3 2023: 2,236 shares worth $116K. The stake represents 0.26% of the portfolio and ranks #11 among its holdings.

58 funds tracked by Wall St. Rank hold IMA as of Q3 2023.

  • OUP Management Company held 2,236 shares of ImageneBio Inc worth $116K as of Q3 2023.
  • ImageneBio Inc was a new OUP Management Company position in Q3 2023.
  • ImageneBio Inc made up 0.26% of OUP Management Company's portfolio in Q3 2023, its #11 holding.
  • 58 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2023.

Based on OUP Management Company's 13F filing for Q3 2023, filed 9 Nov 2023.